Trials / Completed
CompletedNCT02092766
Parenteral Artesunate Compared to Quinine as a Cause of Late Anaemia in African Children With Malaria
Parenteral Artesunate Compared to Quinine as a Cause of Late Post-treatment Anaemia in African Children With Hyperparasitaemic P. Falciparum Malaria
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 217 (actual)
- Sponsor
- University of Oxford · Academic / Other
- Sex
- All
- Age
- 6 Months – 14 Years
- Healthy volunteers
- Not accepted
Summary
Delayed anaemia has been reported in European travellers with malaria cured by artesunate. Although no deaths related to this delayed anaemia have been reported so far, blood transfusion has been necessary in some affected patients. Recent observations suggest that this episodes of anaemia also occurs in endemic countries. The aim of this trial is to assess the incidence of late onset anaemia after treatment with intravenous artesunate compared to intravenous quinine, to identify patients at risk and to clarify the causes of this delayed anaemia.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | artesunate | |
| DRUG | quinine |
Timeline
- Start date
- 2014-06-01
- Primary completion
- 2015-04-01
- Completion
- 2015-04-01
- First posted
- 2014-03-20
- Last updated
- 2015-06-01
Locations
1 site across 1 country: Democratic Republic of the Congo
Source: ClinicalTrials.gov record NCT02092766. Inclusion in this directory is not an endorsement.